Imidazole derivatives of pyrrolidonic and piperidonic acids as potential inhibitors of human placental aromatase in vitro

Journal of Steroid Biochemistry and Molecular Biology

Volumn 57, Issue 1-2, 1996, Pages 73-77

  Baroudi, Moomen ^a   Robert, Jacqueline ^a   Luu Duc, Cuong ^a  

^a UNIV GRENOBLE ALPES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLUTETHIMIDE; AROMATASE; AROMATASE INHIBITOR; IMIDAZOLE DERIVATIVE; PIPERIDINE DERIVATIVE; PYRROLIDINE DERIVATIVE;

ARTICLE; CONTROLLED STUDY; ENZYME INHIBITION; FEMALE; HUMAN; HUMAN CELL; PLACENTA; STRUCTURE ACTIVITY RELATION;

EID: 0029942776     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/0960-0760(95)00253-7     Document Type: Article

References (23)

1. James V. H. T. and Reed M. J.: Steroid hormones and human cancer. Prog. Cancer Res. Ther. 14 (1980) 471-487.
2. Van Wauve J. P. and Jansen P. A. J.: Is there a case for P-450 inhibitors in cancer treatment? J. Med. Chem. 32 (1989) 2231-2239.
3. Perez N. and Borja J.: Aromatase inhibitors: clinical pharmacology and therapeutic implications in breast cancer. J. Int. Med. Res. 20 (1992) 303-312.
4. Banting L., Nicholls P. J., Shaw M. A. and Smith H. J.: Recent developments in aromatase inhibition as potential treatment for oestrogen-dependent breast cancer. Prog. Med. Chem. 26 (1989) 253-298.
5. Brodie A., Brodie H. B., Callard G., Robinson C., Roselli C. and Santen R.: Recent advances in steroid biochemistry and molecular biology. J. Steroid Biochem. Molec. Biol. 44 (1993) 321-695.
6. Brodie A. and Santen R.: Aromatase and its inhibitors in breast cancer treatment. Breast Cancer Res. Treat. 30 (1994) 1-115.
7. Ayub M. and Levell M. J.: Structure-activity relationships of the inhibition of human placental aromatase by imidazole drugs including ketoconazole. J. Steroid Biochem. 31 (1988) 65-72.
8. Nicholls P. J. and Shaw M. A.: Inhibition of human placental aromatase by substituted azoles. Br. J. Pharmac. 92 (1987) 726P.
9. Lang M., Batzl Ch., Furet P., Bowman R., Häussler A. and Bhatnagar A. S.: Structure-activity relationships and binding model of novel aromatase inhibitors. J. Steroid Biochem. Molec. Biol. 44 (1993) 421-428.
10. Geelen J. A. A., Loozen H. J. J., Deckers G. H., de Leeuw R., Kloosterboer H. J. and Lamberts S. W. J.: ORG. 33201: A new highly selective orally active aromatase inhibitor. J. Steroid Biochem. Molec. Biol. 44 (1993) 681-682.
11. Mason J. I., Carr B. R. and Murray B. A.: Imidazole animycotics: selective inhibitors of steroid aromatization and progesterone hydroxylation. Steroids 50 (1987) 179-189.
12. Hida F., Robert J. and Luu-Duc C.: Synthesis and evaluation of benzimidazole and imidazole compounds as potential aromatase inhibitors. Farmaco 49 (1994) 489-492.
13. Barbieri R. L., Gochberg J. and Ryan K. J.: Nicotine, cotinine and anabasine inhibit aromatase in human trophoblast in vitro. J. Clin. Invest. 77 (1986) 1727-1733.
14. Osawa Y., Tochigi B., Tochigi M., Ohnishi S., Watanabe Y., Bullion K., Osawa G., Nakabayashi Y. and Yarborough C.: Aromatase inhibitors in cigarette smoke, tobacco leaves and other plants. J. Enzyme Inhib. 4 (1990) 187-200.
15. Bullion K., Ohnishi S. and Osawa Y.: Competitive inhibition of human placental aromatase by N-K-octanoylnornicotine and other nornicotine derivatives. Endocrine Res. 17 (1991) 409-419.
16. Kadohama N., Shintani K. and Osawa Y.: Tobacco alkaloid derivatives as inhibitors of breast cancer aromatase. Cancer Lett. 75 (1993) 175-182.
17. Baroudi M., Robert J. and Luu-Duc C.: Imidazolides of piperidone carboxylic acids: synthesis and physical properties. Heterocyclic Comm. 1 (1995) 147-151.
18. Ryan K. J.: Biological aromatization of steroids. J. Biol. Chem. 234 (1959) 268-272.
19. Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J.: Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193 (1951) 265-275.
20. Covey D. F., Hood W. F. and Parikh V. D.: 10 β-propynyl-substituted steroids. J. Biol. Chem. 256 (1981) 1076-1079.
21. Thompson E. A. Jr. and Siiteri P. K.: Utilization of oxygen and reduced nicotinamide adenine dinucleotide phosphate by human placental microsomes during aromatization of androstenedione. J. Biol. Chem. 249 (1974) 5364-5372.
22. Rabe T., Rabe D. and Runnenbaum B.: New aromatase assay and its application for inhibitory studies of aminoglutethimide on microsomes of human term placenta. J. Steroid. Biochem. 17 (1982) 305-309.
23. Jones C. D., Winter M. A., Hirsch K. S., Stamm N., Taylor H. M., Holden H. E., Davenport J. D., Krumkalns E. V. and Suhr R. G.: Estrogen synthetase inhibitors. Comparison of the in vitro aromatase inhibitory activity for a variety of nitrogen heterocycles substituted with diarylmethane or diarylmethanol groups. J. Med. Chem. 33 (1990) 416-429.